Clinical Trial Update: Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating aripiprazole for post-traumatic stress disorder symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Posttraumatic Stress Disorder | Phase 3 | Status: COMPLETED